These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 26444770)

  • 1. Structural Neuroimaging Genetics Interactions in Alzheimer's Disease.
    Moon SW; Dinov ID; Kim J; Zamanyan A; Hobel S; Thompson PM; Toga AW
    J Alzheimers Dis; 2015; 48(4):1051-63. PubMed ID: 26444770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Brain Changes in Early-Onset Alzheimer's Disease Subjects Using the LONI Pipeline Environment.
    Moon SW; Dinov ID; Hobel S; Zamanyan A; Choi YC; Shi R; Thompson PM; Toga AW;
    J Neuroimaging; 2015; 25(5):728-37. PubMed ID: 25940587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Classifying Alzheimer's disease with brain imaging and genetic data using a neural network framework.
    Ning K; Chen B; Sun F; Hobel Z; Zhao L; Matloff W; ; Toga AW
    Neurobiol Aging; 2018 Aug; 68():151-158. PubMed ID: 29784544
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of EPHA1 genetic variation on cerebrospinal fluid and neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
    Wang HF; Tan L; Hao XK; Jiang T; Tan MS; Liu Y; Zhang DQ; Yu JT;
    J Alzheimers Dis; 2015; 44(1):115-23. PubMed ID: 25182741
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of HMGCR genetic variation on neuroimaging biomarkers in healthy, mild cognitive impairment and Alzheimer's disease cohorts.
    Cao L; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Yu JT; Tan L;
    Oncotarget; 2016 Mar; 7(12):13319-27. PubMed ID: 26950278
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Volumes of lateral temporal and parietal structures distinguish between healthy aging, mild cognitive impairment, and Alzheimer's disease.
    Hänggi J; Streffer J; Jäncke L; Hock C
    J Alzheimers Dis; 2011; 26(4):719-34. PubMed ID: 21709375
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impacts of CD33 Genetic Variations on the Atrophy Rates of Hippocampus and Parahippocampal Gyrus in Normal Aging and Mild Cognitive Impairment.
    Wang WY; Liu Y; Wang HF; Tan L; Sun FR; Tan MS; Tan CC; Jiang T; Tan L; Yu JT;
    Mol Neurobiol; 2017 Mar; 54(2):1111-1118. PubMed ID: 26803496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic studies of quantitative MCI and AD phenotypes in ADNI: Progress, opportunities, and plans.
    Saykin AJ; Shen L; Yao X; Kim S; Nho K; Risacher SL; Ramanan VK; Foroud TM; Faber KM; Sarwar N; Munsie LM; Hu X; Soares HD; Potkin SG; Thompson PM; Kauwe JS; Kaddurah-Daouk R; Green RC; Toga AW; Weiner MW;
    Alzheimers Dement; 2015 Jul; 11(7):792-814. PubMed ID: 26194313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Effect of the APOE Genotype on Individual BrainAGE in Normal Aging, Mild Cognitive Impairment, and Alzheimer's Disease.
    Löwe LC; Gaser C; Franke K;
    PLoS One; 2016; 11(7):e0157514. PubMed ID: 27410431
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biomarker Extraction Based on Subspace Learning for the Prediction of Mild Cognitive Impairment Conversion.
    Li Y; Fang Y; Wang J; Zhang H; Hu B
    Biomed Res Int; 2021; 2021():5531940. PubMed ID: 34513992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural magnetic resonance imaging for the early diagnosis of dementia due to Alzheimer's disease in people with mild cognitive impairment.
    Lombardi G; Crescioli G; Cavedo E; Lucenteforte E; Casazza G; Bellatorre AG; Lista C; Costantino G; Frisoni G; Virgili G; Filippini G
    Cochrane Database Syst Rev; 2020 Mar; 3(3):CD009628. PubMed ID: 32119112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene interactions and structural brain change in early-onset Alzheimer's disease subjects using the pipeline environment.
    Moon SW; Dinov ID; Zamanyan A; Shi R; Genco A; Hobel S; Thompson PM; Toga AW;
    Psychiatry Investig; 2015 Jan; 12(1):125-35. PubMed ID: 25670955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Random forest feature selection, fusion and ensemble strategy: Combining multiple morphological MRI measures to discriminate among healhy elderly, MCI, cMCI and alzheimer's disease patients: From the alzheimer's disease neuroimaging initiative (ADNI) database.
    Dimitriadis SI; Liparas D; Tsolaki MN;
    J Neurosci Methods; 2018 May; 302():14-23. PubMed ID: 29269320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural, static, and dynamic functional MRI predictors for conversion from mild cognitive impairment to Alzheimer's disease: Inter-cohort validation of Shanghai Memory Study and ADNI.
    Chen Z; Chen K; Li Y; Geng D; Li X; Liang X; Lu H; Ding S; Xiao Z; Ma X; Zheng L; Ding D; Zhao Q; Yang L;
    Hum Brain Mapp; 2024 Jan; 45(1):e26529. PubMed ID: 37991144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visualizing modules of coordinated structural brain atrophy during the course of conversion to Alzheimer's disease by applying methodology from gene co-expression analysis.
    Sato K; Mano T; Matsuda H; Senda M; Ihara R; Suzuki K; Arai H; Ishii K; Ito K; Ikeuchi T; Kuwano R; Toda T; Iwatsubo T; Iwata A;
    Neuroimage Clin; 2019; 24():101957. PubMed ID: 31400633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multiple genetic imaging study of the association between cholesterol metabolism and brain functional alterations in individuals with risk factors for Alzheimer's disease.
    Bai F; Yuan Y; Shi Y; Zhang Z
    Oncotarget; 2016 Mar; 7(13):15315-28. PubMed ID: 26985771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
    Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
    Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lack of neural compensatory mechanisms of BDNF val66met met carriers and APOE E4 carriers in healthy aging, mild cognitive impairment, and Alzheimer's disease.
    Gomar JJ; Conejero-Goldberg C; Huey ED; Davies P; Goldberg TE;
    Neurobiol Aging; 2016 Mar; 39():165-73. PubMed ID: 26923413
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variation and neuroimaging measures in Alzheimer disease.
    Biffi A; Anderson CD; Desikan RS; Sabuncu M; Cortellini L; Schmansky N; Salat D; Rosand J;
    Arch Neurol; 2010 Jun; 67(6):677-85. PubMed ID: 20558387
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mining Outcome-relevant Brain Imaging Genetic Associations via Three-way Sparse Canonical Correlation Analysis in Alzheimer's Disease.
    Hao X; Li C; Du L; Yao X; Yan J; Risacher SL; Saykin AJ; Shen L; Zhang D;
    Sci Rep; 2017 Mar; 7():44272. PubMed ID: 28291242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.